The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. This year’s metric has recorded a Price increase of 6.44%. However, over the past six months, we’ve seen a weaker performance of 9.88%. The price of TAK fallen by 1.53% over the last 30 days. And in the last five days, it has surged by 3.64%.
The stock price for Takeda Pharmaceutical Co ADR (TAK) currently stands at $14.97. The stock experienced a substantial increase in the last session, hitting $18.71 after starting at $14.96. The stock’s lowest price was $14.94 before closing at $14.8.
Takeda Pharmaceutical Co ADR saw a rather consistency, in terms of market performance. The company’s stock reached its highest point at $15.53 on 07/01/25, while the lowest price for the same duration was marked at $12.80 on 01/23/25.
52-week price history of TAK Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Takeda Pharmaceutical Co ADR’s current trading price is -3.64% away from its 52-week high, while its distance from the 52-week low is 16.91%. The stock’s price range during this period has varied between$12.80 and $15.53. The Takeda Pharmaceutical Co ADR’s shares, which operate in the Healthcare, saw a trading volume of around 0.97 million for the day, a figure considerably lower than their average daily volume of 3.25 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Takeda Pharmaceutical Co ADR (TAK) has experienced a quarterly rise of 6.89% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 46.75B and boasts a workforce of 47455 employees.
Takeda Pharmaceutical Co ADR: Analysts’ Ratings Unveiled
As of right now, 3 analysts are rating Takeda Pharmaceutical Co ADR as a BUY, 0 of the polled analysts branded the stock as an OVERWEIGHT, 1 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 14.74, with a change in price of -0.03. Similarly, Takeda Pharmaceutical Co ADR recorded 2,933,121 in trading volume during the last 100 days, posting a change of -0.23%.
TAK’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for TAK stands at 0.66. Similarly, the long-term debt-to-equity ratio is also 0.60.
TAK Stock Stochastic Average
As of today, Takeda Pharmaceutical Co ADR’s raw stochastic average for the last 50 days stands at 72.79%. This is a decline compared to the raw stochastic average of the previous 20 days, which was noted at 97.06%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 95.37% and 88.77%, respectively.
